The role of visfatin (PBEF/Nampt) in pregnancy complications

J 2015

The role of visfatin (PBEF/Nampt) in pregnancy complications

PAVLOVÁ, Tereza, Jan NOVÁK and Julie BIENERTOVÁ VAŠKŮ

Basic information

Original name

The role of visfatin (PBEF/Nampt) in pregnancy complications

Authors

PAVLOVÁ, Tereza (203 Czech Republic, guarantor, belonging to the institution), Jan NOVÁK (203 Czech Republic, belonging to the institution) and Julie BIENERTOVÁ VAŠKŮ (203 Czech Republic, belonging to the institution)

Edition

Journal of Reproductive Immunology, Shannon, Elsevier Ireland LTD, 2015, 0165-0378

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 3.202

RIV identification code

RIV/00216224:14110/15:00086064

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.jri.2015.09.004

UT WoS

000365370500018

Keywords in English

Preterm labor; Pre-eclampsia; Gestational diabetes mellitus; Maternal plasma; Sirtuins; Visfatin

Abstract

V originále

Visfatin (PBEF/Nampt) is an adipocytokine that exerts pleiotropic effects within the human body, particularly affecting its metabolism and immunity. Visfatin was originally identified as being secreted by peripheral blood lymphocytes acting as a pre-B-cell colony-enhancing factor (PBEF). However, it was subsequently reported to be expressed in almost every tissue of the human body, with visceral fat deposits being the main source of visfatin. In addition to its secreted form, visfatin may also be found intracellularly where it functions as a nicotinamide phosphoribosyltransferase (Nampt). Visfatin maternal plasma concentrations increase during pregnancy, suggesting its important role in this complicated process. Alterations in visfatin level also take place in patients during pregnancy complications. This review focuses on the ones that most commonly occur in connection with visfatin: preterm labor, pre-eclampsia and gestational diabetes mellitus. The review aims to provide a better understanding of the role of visfatin during pregnancy and the causes of its alteration in maternal plasma, highlighting the potential use of visfatin as a diagnostic marker of pregnancy complications in the future. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Links

MUNI/FR/0308/2014, interní kód MU

Name: Manuál pro zvýšení publikační gramotnosti pre- i postgraduálních studentů, obsahující základní poznatky a návody po tvorbu publikací různých typů (Acronym: Manuál pro přípravu publikací)

Investor: Masaryk University

Citovat

PAVLOVÁ, Tereza, Jan NOVÁK and Julie BIENERTOVÁ VAŠKŮ. The role of visfatin (PBEF/Nampt) in pregnancy complications. Journal of Reproductive Immunology. Shannon: Elsevier Ireland LTD, 2015, vol. 112, NOV 2015, p. 102-110. ISSN 0165-0378. Available from: https://dx.doi.org/10.1016/j.jri.2015.09.004.

@article{1331397,
   author = {Pavlová, Tereza and Novák, Jan and Bienertová Vašků, Julie},
   article_location = {Shannon},
   article_number = {NOV 2015},
   doi = {http://dx.doi.org/10.1016/j.jri.2015.09.004},
   keywords = {Preterm labor; Pre-eclampsia; Gestational diabetes mellitus; Maternal plasma; Sirtuins; Visfatin},
   language = {eng},
   issn = {0165-0378},
   journal = {Journal of Reproductive Immunology},
   title = {The role of visfatin (PBEF/Nampt) in pregnancy complications},
   volume = {112},
   year = {2015}
}

TY  - JOUR
ID  - 1331397
AU  - Pavlová, Tereza - Novák, Jan - Bienertová Vašků, Julie
PY  - 2015
TI  - The role of visfatin (PBEF/Nampt) in pregnancy complications
JF  - Journal of Reproductive Immunology
VL  - 112
IS  - NOV 2015
SP  - 102-110
EP  - 102-110
PB  - Elsevier Ireland LTD
SN  - 01650378
KW  - Preterm labor
KW  - Pre-eclampsia
KW  - Gestational diabetes mellitus
KW  - Maternal plasma
KW  - Sirtuins
KW  - Visfatin
N2  - Visfatin (PBEF/Nampt) is an adipocytokine that exerts pleiotropic effects within the human body, particularly affecting its metabolism and immunity. Visfatin was originally identified as being secreted by peripheral blood lymphocytes acting as a pre-B-cell colony-enhancing factor (PBEF). However, it was subsequently reported to be expressed in almost every tissue of the human body, with visceral fat deposits being the main source of visfatin. In addition to its secreted form, visfatin may also be found intracellularly where it functions as a nicotinamide phosphoribosyltransferase (Nampt). Visfatin maternal plasma concentrations increase during pregnancy, suggesting its important role in this complicated process. Alterations in visfatin level also take place in patients during pregnancy complications. This review focuses on the ones that most commonly occur in connection with visfatin: preterm labor, pre-eclampsia and gestational diabetes mellitus. The review aims to provide a better understanding of the role of visfatin during pregnancy and the causes of its alteration in maternal plasma, highlighting the potential use of visfatin as a diagnostic marker of pregnancy complications in the future. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
ER  -

PAVLOVÁ, Tereza, Jan NOVÁK and Julie BIENERTOVÁ VAŠKŮ. The role of visfatin (PBEF/Nampt) in pregnancy complications. \textit{Journal of Reproductive Immunology}. Shannon: Elsevier Ireland LTD, 2015, vol.~112, NOV 2015, p.~102-110. ISSN~0165-0378. Available from: https://dx.doi.org/10.1016/j.jri.2015.09.004.

Detailed Information on Publication Record